RecruitingDiabetes Mellitus, Type 2

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Eligible age

18–70 yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Participation in the study will last about 26 weeks.

Sponsor: Eli Lilly and Company

You may qualify if…

✓ Have type 2 diabetes
✓ Are receiving ≥20 units of basal insulin per day and ≤55 units/day and ≤1.5 units/kg/day at screening
✓ Have hemoglobin A1c (HbA1c) 7.5% to 10.5% inclusive
✓ Have a body mass index (BMI) of 20 or higher and less than 35 kilograms per square meter (kg/m2)